The novel pleuromutilin derivative 22-((4-((4-nitrophenyl)acetamido)phenyl)thio)deoxy pleuromutilin possesses robust anti-mycoplasma activity both <i>in vitro</i> and <i>in vivo</i>.

Front Pharmacol · 2024 · PMC11695783 · PMID 39759447

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

P< 0.05, the difference was significant; P< 0.01, the difference was extremely significant.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.